Literature DB >> 20846734

Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases.

Swamidas V Jamema1, Christian Kirisits, Umesh Mahantshetty, Petra Trnkova, Deepak D Deshpande, Shyam K Shrivastava, Richard Pötter.   

Abstract

PURPOSE: Comparison of inverse planning with the standard clinical plan and with the manually optimized plan based on dose-volume parameters and loading patterns.
MATERIALS AND METHODS: Twenty-eight patients who underwent MRI based HDR brachytherapy for cervix cancer were selected for this study. Three plans were calculated for each patient: (1) standard loading, (2) manual optimized, and (3) inverse optimized. Dosimetric outcomes from these plans were compared based on dose-volume parameters. The ratio of Total Reference Air Kerma of ovoid to tandem (TRAK(O/T)) was used to compare the loading patterns.
RESULTS: The volume of HR CTV ranged from 9-68 cc with a mean of 41(±16.2) cc. Mean V100 for standard, manual optimized and inverse plans was found to be not significant (p=0.35, 0.38, 0.4). Dose to bladder (7.8±1.6 Gy) and sigmoid (5.6±1.4 Gy) was high for standard plans; Manual optimization reduced the dose to bladder (7.1±1.7 Gy p=0.006) and sigmoid (4.5±1.0 Gy p=0.005) without compromising the HR CTV coverage. The inverse plan resulted in a significant reduction to bladder dose (6.5±1.4 Gy, p=0.002). TRAK was found to be 0.49(±0.02), 0.44(±0.04) and 0.40(±0.04) cGy m(-2) for the standard loading, manual optimized and inverse plans, respectively. It was observed that TRAK(O/T) was 0.82(±0.05), 1.7(±1.04) and 1.41(±0.93) for standard loading, manual optimized and inverse plans, respectively, while this ratio was 1 for the traditional loading pattern.
CONCLUSIONS: Inverse planning offers good sparing of critical structures without compromising the target coverage. The average loading pattern of the whole patient cohort deviates from the standard Fletcher loading pattern.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20846734     DOI: 10.1016/j.radonc.2010.08.011

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

Review 1.  A review of recent developments in image-guided radiation therapy in cervix cancer.

Authors:  Azmat H Sadozye; Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

2.  Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low-field MRI study.

Authors:  M P Schmid; B Mansmann; M Federico; J C A Dimopoulous; P Georg; E Fidarova; W Dörr; R Pötter
Journal:  Strahlenther Onkol       Date:  2013-01-25       Impact factor: 3.621

3.  Will MR image-guided brachytherapy be a standard of care for cervical cancer in future? An Indian perspective.

Authors:  D D Deshpande
Journal:  J Med Phys       Date:  2012-01

4.  Virtual modelling of novel applicator prototypes for cervical cancer brachytherapy.

Authors:  Primoz Petric; Robert Hudej; Noora Al-Hammadi; Barbara Segedin
Journal:  Radiol Oncol       Date:  2016-11-09       Impact factor: 2.991

5.  Model assessment of individual tumor control rate and adverse effects in comparing locally advanced cervical cancer treatment using intracavitary with and without interstitial brachytherapy.

Authors:  Hsiang-Chi Kuo; Keyur J Mehta; Ravindra Yaparpalvi; Viswanathan Shankar; William Bodner; Madhur Garg; Amanda Rivera; Wolfgang A Tomé; Shalom Kalnicki
Journal:  J Contemp Brachytherapy       Date:  2016-12-20

6.  Influence of dwell time homogeneity error weight parameter on treatment plan quality in inverse optimized high-dose-rate cervix brachytherapy using SagiPlan.

Authors:  Mohammad Amin Mosleh-Shirazi; Elham Shahcheraghi-Motlagh; Mohammad Hadi Gholami; Alireza Shakibafard; Sareh Karbasi; Reza Fardid
Journal:  J Contemp Brachytherapy       Date:  2019-06-28

7.  The usefulness of an independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix.

Authors:  Yutaka Takahashi; Masahiko Koizumi; Iori Sumida; Fumiaki Isohashi; Toshiyuki Ogata; Yuichi Akino; Yasuo Yoshioka; Shintaro Maruoka; Shinichi Inoue; Koji Konishi; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2012-07-17       Impact factor: 2.724

8.  Does help structures play a role in reducing the variation of dwell time in IPSA planning for gynaecological brachytherapy application?

Authors:  Swamidas Jamema; Umesh Mahantshetty; Dd Deshpande; Smriti Sharma; Sk Shrivastava
Journal:  J Contemp Brachytherapy       Date:  2011-09-30

9.  IMRT, IGRT, and other high technology becomes standard in external beam radiotherapy: But is image-guided brachytherapy for cervical cancer too expensive?

Authors:  Jamema V Swamidas; Christian Kirisits
Journal:  J Med Phys       Date:  2015 Jan-Mar

10.  Does inverse planning improve plan quality in interstitial high-dose-rate breast brachytherapy?

Authors:  Tibor Major; Georgina Fröhlich; Norbert Mészáros; Viktor Smanykó; Csaba Polgár
Journal:  J Contemp Brachytherapy       Date:  2020-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.